Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 2, 2013, Pages 447-455

  Lv, Wei ^a   Luo, Jie ^a   Deng, Ying ^a   Sun, Yuyu ^a  

^a University of South Dakota   (United States)

Author keywords

Antimicrobial; Chitosan; Drug delivery; Polyurethane; Rechargeable

Indexed keywords

ANTIMICROBIAL; ANTIMICROBIAL DRUG; BIOMATERIAL SURFACES; BIOMEDICAL APPLICATIONS; COVALENTLY BONDED; MEDICAL DEVICES; METHACRYLIC ACIDS; MICROBIAL CONTAMINATION; RECHARGEABLE;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMEDICAL EQUIPMENT; CHITOSAN; DRUG DELIVERY; GRAFTING (CHEMICAL); MECHANICAL PROPERTIES; MEDICAL APPLICATIONS; POLYURETHANES;

MICROORGANISMS;

CHITOSAN; CIPROFLOXACIN; METHACRYLIC ACID; POLYURETHAN; RIFAMPICIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTACT ANGLE; CONTROLLED STUDY; COVALENT BOND; DRUG BINDING; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; IMMOBILIZATION; NONHUMAN; SKIN FIBROBLAST; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BIOCOMPATIBLE MATERIALS; BIOFILMS; CELL SURVIVAL; CHITOSAN; CIPROFLOXACIN; DRUG DELIVERY SYSTEMS; FIBROBLASTS; MEMBRANES, ARTIFICIAL; MICROBIAL SENSITIVITY TESTS; OZONE; POLYURETHANES; RATS; RATS, SPRAGUE-DAWLEY; RIFAMPIN; SURFACE PROPERTIES; TIME FACTORS;

EID: 84872681925     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34350     Document Type: Article

References (38)

1. Hall-Stoodley L., Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2: 95-108.
2. Biering-Sorensen F. Urinary tract infection in individuals with spinal cord lesion. Curr Opin Urol 2002; 12: 45-49.
3. Choong S, Whitfield H. Biofilms and their role in infections in urology. Bju Int 2000; 86: 935-941.
4. Costerton JW. Introduction to biofilm. Int J Antimicrob Agents 1999; 11: 217-221.
5. Habash M, Reid G. Microbial biofilms: Their development and significance for medical device-related infections. J Clin Pharmacol 1999; 39: 887-898.
6. Kunin CM, Chin QF, Chambers S. Formation of encrustations on indwelling urinary catheters in the elderly: A comparison of different types of catheter materials in blockers and nonblockers. J Urol 1987; 138: 899-902.
7. Liedl B. Catheter-associated urinary tract infections. Curr Opin Urol 2001; 11: 75-79.
8. Rossi G. Biofilms in infectious diseases. Recenti Prog Med 2003; 94: 537-539.
9. Tenke P, Riedl CR, Jones G.L., Williams GJ, Stickler D, Nagy E. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int J Antimicrob Agents 2004; 23 (Suppl 1): 67-74.
10. Gorman SP, McGovern JG, Woolfson A.D., Adair CG, Jones DS The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilator-associated pneumonia. Biomaterials 2001; 22: 2741-2747.
11. Ramage G, Tunney MM, Patrick S, Gorman S.P., Nixon JR Formation of propionibacterium acnes biofilms on orthopedic biomaterials and their susceptibility to antimicrobials. Biomaterials 2003; 24: 3221-3227.
12. Chaiban G, Hanna H, Dvorak T., Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: A novel antiseptic agent. J Antimicrobial Chemother 2005; 55: 51-56.
13. Pai MP, Pendland SL, Danziger LH Antimicrobial-coated/bonded and -impregnated intravascular catheters. Ann Pharmacother 2001; 35: 1255-1263.
14. von Eiff C., Jansen B, Kohnen W., Becker K. Infections associated with medical devices - Pathogenesis, management and prophylaxis. Drugs 2005; 65: 179-214.
15. Cao ZB, Sun YY Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems. J Biomed Mater Res A 2009; 89A: 960-967.
16. Yamaguchi I, Itoh S, Suzuki M., Osaka A, Tanaka J. The chitosan prepared from crab tendons: II. Biomaterials 2003; 24: 3285-3292.
17. Aoki T, Iskandar S, Yoshida T., Takahashi K, Hattori M. Reduced immunogenicity of beta-lactoglobulin by conjugating with chitosan. Biosci Biotechnol Biochem 2006; 70: 2349-2356.
18. Carlson RP, Taffs R, Davison W.M., Stewart PS Anti-biofilm properties of chitosan-coated surfaces. J Biomater Sci Polym Ed 2008; 19: 1035-1046.
19. Fan LH, Du YM, Zhang B.Z., Yang JH, Zhou JP, Kennedy JF Preparation and properties of alginate/carboxyrnethyl chitosan blend fibers. Carbohydr Polym 2006; 65: 447-452.
20. Fukuda H, Kikuchi Y. In vitro clot formation on the polyelectrolyte complexes of sodium dextran surface with chitosan. J Biomed Mater Res 1978; 12: 531-539.
21. Lee KY, Ha WS, Park WH Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 1995; 16: 1211-1216.
22. Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003; 4: 1457-1465.
23. Sudarshan NR, Hoover DG, Knorr D. Antibacterial action of chitosan. Food Biotechnol 1992; 6: 257-272.
24. Frew JEJP, Scholes G. Spectrophotometric determination of hydrogen peroxide and organic hydroperoxides at low concentration in aqueous solution. Anal Chim Acta 1983; 155: 139-150.
25. Park JC, Hwang YS, Lee J.E., Park KD, Matsumura K, Hyon SH, Suh H. Type I atelocollagen grafting onto ozone-treated polyurethane films: Cell attachment, proliferation, and collagen synthesis. J Biomed Mater Res 2000; 52: 669-677.
26. Liao JD, Lin SP, Wu YT Dual properties of the deacetylated sites in chitosan for molecular immobilization and biofunctional effects. Biomacromolecules 2005; 6: 392-399.
27. Hu SG, Jou CH, Yang MC Biocompatibility and antibacterial activity of chitosan and collagen immobilized poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid). Carbohydr Polym 2004; 58: 173-179.
28. Karlsson JO, Gatenholm P. Solid-supported wettable hydrogels prepared by ozone induced grafting. Polymer 1996; 37: 4251-4256.
29. Saxena S, Ray AR, Gupta B. Chitosan immobilization on polyacrylic acid grafted polypropylene monofilament. Carbohydr Polym 2010; 82: 1315-1322.
30. Shavi G, Nayak UY, Reddy M.S., Karthik A., Deshpande PB, Kumar AR, Udupa N. Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med 2011; 22: 865-878.
31. Sutani K, Kaetsu I, Uchida K., Matsubara Y. Stimulus responsive drug release from polymer gel. Controlled release of ionic drug from polyampholyte gel. Radiat Phys Chem 2002; 64: 331-336.
32. Wagner KG, Gruetzmann R. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings. Aaps J 2005; 7: 668-677.
33. Banerjee UC, Saxena B, Chisti Y. Biotransformations of rifamycins: Process possibilities. Biotechnol Adv 1992; 10: 577-595.
34. Williams KJ, Piddock LJ Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 597-603.
35. Dorr T, Vulic M, Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. Plos Biol 2010; 8: 1-8.
36. Olayinka AA, Anthony JA, Anthony IO Synergistic interaction of Helichrysum pedunculatum leaf extracts with antibiotics against wound infection associated bacteria. Biol Res 2009; 42: 327-338.
37. Santander-Ortega M.J., Stauner T, Loretz B., Ortega-Vinuesa JL, Bastos-Gonzalez D, Wenz G., Schaefer UF, Lehr CM Nanoparticles made from novel starch derivatives for transdermal drug delivery. J Controlled Release 2010; 141: 85-92.
38. Chatelet C, Damour O, Domard A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 2001; 22: 261-268.